Hainan Poly Pharm Co Ltd is a high-risk pharmaceutical company based in China. Specializing in the production of injections, tablets, and other pharmaceutical products, they offer a wide range of medications including Azithromycin and Ganciclovir Sodium. With an ESG score of 34.5, Hainan Poly Pharm Co Ltd is a key player in the pharmaceutical industry in China.